News & Updates
Filter by Specialty:
Immunosuppression treatment with mTORi carries risk of ovarian cyst
Among women receiving immunosuppression treatment with mammalian target of rapamycin inhibitors (mTORi), the incidence of ovarian cyst appears to be a common adverse event, according to the results of a systematic review and meta-analysis.
Immunosuppression treatment with mTORi carries risk of ovarian cyst
06 Oct 2021
Extended letrozole therapy improves DFS in postmenopausal women with breast cancer
Extending treatment with letrozole for 5 years improves disease-free survival (DFS) rates in postmenopausal women with early-stage breast cancer who have already received tamoxifen for 2–3 years, according to the GIM4* trial.
Extended letrozole therapy improves DFS in postmenopausal women with breast cancer
06 Oct 2021
Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers
In the treatment of women with acute ischaemic stroke, mechanical thrombectomy is effective and can be safely performed during pregnancy or the postpartum period, as shown in a study.
Thrombectomy a viable first-line therapy for stroke in pregnant women, new mothers
05 Oct 2021
Oteseconazole bests fluconazole for vaginal yeast infections
Oteseconazole (VT-1161), a novel investigational fungal CYP51 inhibitor, outdid fluconazole/placebo for managing acute and recurrent* vulvovaginal candidiasis (VVC), according to data from the phase III ultraVIOLET trial.
Oteseconazole bests fluconazole for vaginal yeast infections
05 Oct 2021
Gestational diabetes bears increased hazard of microalbuminuria in third trimester
Among women with gestational diabetes mellitus, microalbuminuria may occur in the third trimester despite exposure to only a brief period of overt hyperglycaemia, a study has found.
Gestational diabetes bears increased hazard of microalbuminuria in third trimester
04 Oct 2021
Cervical adenocarcinoma has good survival rates when caught, treated early
Cervical adenocarcinoma has at least a 50 percent survival rate which can be further improved by early diagnosis and individualized and comprehensive treatment, a recent study has found.
